Strontium Deficiency: What the Evidence Shows

Here is the honest bottom line, stated plainly so you can stop worrying about it: there is no such thing as strontium deficiency in humans. Strontium is not an essential nutrient — your body has no known job that requires it, there is no recommended intake, no blood test that defines a "low" level, and no recognized deficiency disease. You will never be told you are "low in strontium," because the concept does not exist in medicine. The reason strontium comes up at all in bone-health conversations is something different and easily confused with a nutrient story: a prescription drug called strontium ranelate, which delivers a pharmacological — that is, drug-sized, far above dietary — dose of strontium and was studied for osteoporosis. That drug is not a vitamin you are missing; it is a medication with real benefits in fracture studies and real safety limits (including a heart-attack signal) that led regulators to restrict it. This page exists to set the record straight: to explain why there is no deficiency to correct, what the everyday trace of strontium in your food and bones actually is, who (if anyone) ever runs genuinely short, and what the sensible, low-key thing to do is — which, for almost everyone, is nothing.


Table of Contents

  1. What the Evidence Says
  2. Why There Is No Deficiency: The Biology
  3. The Real Story: Strontium Ranelate Is a Drug, Not a Nutrient
  4. Who, If Anyone, Ever Runs Short
  5. Is There a Test for “Low Strontium”?
  6. What to Do (Almost Always: Nothing Special)
  7. When to Talk to a Doctor
  8. Related Nutrients and Pages
  9. Key Research Papers
  10. Connections
  11. Featured Videos

What the Evidence Says

Let us be candid, because vague language is exactly how supplement marketing slips an "essential" claim past you. Strontium is not classified as an essential element for humans. An essential nutrient is one your body genuinely needs — remove it from the diet and a specific, reproducible deficiency disease appears (think scurvy from missing vitamin C, or rickets from missing vitamin D). Strontium fails that test on every count:

You may have seen strontium described, in older or speculative writing, as a "possibly beneficial ultratrace element." That phrasing reflects laboratory and animal observations that strontium can interact with bone tissue — not evidence that humans require it or that a deficiency state exists. Reviews of strontium biology are clear on the distinction: strontium's effects on bone are interesting and even useful pharmacologically, but they do not make it a dietary essential, and no human deficiency has been described (Pors Nielsen, 2004). It is correct, and genuinely useful to you, for this page to say so directly rather than manufacture a problem.

If a product or article is trying to sell you on "correcting a strontium deficiency," that is a red flag in itself: it is asserting a condition that medicine does not recognize.

Back to Table of Contents


Why There Is No Deficiency: The Biology

To understand why you can't be deficient in strontium, it helps to know what strontium is and how it behaves in the body. Strontium (chemical symbol Sr) sits directly below calcium on the periodic table, which is the whole key to the story. Elements in the same column behave chemically alike, and to your body's bone-building machinery, strontium looks like a slightly heavier, slightly clumsier version of calcium.

Here is a useful analogy. Imagine your skeleton is built from a specific brand of brick — calcium. Strontium is a near-identical brick from a different factory: it fits in the same slots, so when it happens to be lying around, the masons (your bone cells) will occasionally lay one into the wall. But the building was never designed for the substitute brick, the supply of real calcium bricks is what the plans call for, and the structure does not depend on the substitute being present at all. That is why strontium accumulates in bone — it gets incorporated into the mineral crystal alongside calcium — without ever being something the bone requires. About 99% of the body's strontium ends up in the skeleton and teeth, riding along the same handling pathways the body uses for calcium (Pors Nielsen, 2004).

Two consequences follow directly, and together they explain the absence of any deficiency:

There is one more reason a "low strontium" worry makes no biological sense: because strontium and calcium share the same transport machinery, your strontium status simply tracks your calcium intake and your environment. If you eat and drink normally, you take in strontium automatically; the body neither hoards it as if it were precious nor suffers when intake is modest. It is along for the ride.

Back to Table of Contents


The Real Story: Strontium Ranelate Is a Drug, Not a Nutrient

Almost all genuine medical interest in strontium traces to one thing, and it is essential to separate it from any nutrient idea: strontium ranelate, a prescription medication once used for severe osteoporosis. This is the single biggest source of confusion, because it lets supplement sellers borrow the credibility of real fracture trials and quietly imply that your body needs strontium. It does not. Here is the honest picture.

It is a drug-sized dose, far above anything dietary. Strontium ranelate delivered roughly 680 mg of elemental strontium per day — hundreds of times the few milligrams you get from food. At that pharmacological dose, strontium stops being a passive passenger and starts actively influencing bone cells. Laboratory work suggests it does two things at once: it modestly nudges bone-building cells (osteoblasts) to do more, while restraining bone-removing cells (osteoclasts) — a "dual action" that, on paper, tips the balance toward bone formation (Marie, 2006). This is a drug effect at a drug dose, not evidence of a nutrient your diet is short on.

The fracture trials were real. In large randomized, placebo-controlled trials in postmenopausal women with osteoporosis, strontium ranelate reduced fractures. The SOTI trial showed a reduction in new vertebral (spine) fractures over three years (Meunier et al., 2004), and the TROPOS trial showed a reduction in nonvertebral fractures, including a benefit in hip-fracture risk among higher-risk women (Reginster et al., 2005). Earlier dose-finding work had already pointed to these effects (Meunier et al., 2002). So the benefit was not imaginary.

But the bone-density numbers were partly an illusion — and the safety record forced a retreat. Two cautions matter enormously and are exactly what marketing leaves out:

The takeaway is the heart of this page: the strontium ranelate story is a pharmacology story with genuine benefits and genuine risks at a high dose — it is not, and was never, evidence that ordinary people are "deficient" in strontium or need to supplement it. Over-the-counter "strontium for bones" products (often strontium citrate) are sometimes marketed by leaning on the ranelate trials, but they are not the studied drug, are not regulated as a medicine, will still inflate your DEXA reading (potentially misleading you and your doctor), and carry the same unresolved cardiovascular question without the trial oversight. For the full evidence review, see the main Strontium for Bone Health page; for what actually works for bones, see Osteoporosis and its treatment deep-dives.

Back to Table of Contents


Who, If Anyone, Ever Runs Short

Because strontium is not essential, "running short" is not a meaningful clinical event — there is no function to lose. The honest answer to "who is deficient?" is "no one, in any way that matters." But to be thorough and to address the edge cases people sometimes ask about, here is where unusually low strontium exposure can occur, and why none of it amounts to a deficiency requiring treatment:

Notice the pattern: in every situation where strontium intake is low, the documented health concerns are about other nutrients (especially calcium and vitamin D) or about the underlying illness — never about the strontium itself. That is exactly what you would expect for a non-essential element.

Back to Table of Contents


Is There a Test for “Low Strontium”?

People sometimes ask whether a blood test or hair-mineral analysis can reveal a strontium deficiency. The candid answer is that there is no clinical test for strontium status, because there is no status to measure against. A few points worth knowing:

Back to Table of Contents


What to Do (Almost Always: Nothing Special)

This is the practical, low-key part, and it is short by design. For the overwhelming majority of people, the correct action regarding "strontium deficiency" is to recognize that it isn't a thing and redirect that energy toward what genuinely protects bone.

In short: there is nothing to correct, nothing to monitor, and nothing to buy. That is a good-news ending, not a gap in your care.

Back to Table of Contents


When to Talk to a Doctor

Because strontium deficiency is not a real condition, there are no "deficiency symptoms" to watch for. But the topics that bring people to this page — bone health and any use of strontium products — do have moments that warrant a conversation with a clinician. Reach out to your doctor if any of the following apply:

For genuine, time-sensitive bone or fracture concerns, follow the guidance on the disease pages rather than anything on this nutrient-myth page.

Back to Table of Contents


Strontium's whole significance comes from its chemical kinship with calcium and its place in the bone-health conversation. These pages cover the things that actually matter for bone — and the other side of the strontium story:

Back to Table of Contents


Key Research Papers

  1. Pors Nielsen S (2004). The biological role of strontium. Bone;35(3):583-588. — DOI: 10.1016/j.bone.2004.04.026
  2. Meunier PJ, Roux C, Seeman E, Ortolani S, Badurski JE, et al. (2004). The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis (SOTI). New England Journal of Medicine;350(5):459-468. — DOI: 10.1056/NEJMoa022436
  3. Reginster JY, Seeman E, De Vernejoul MC, Adami S, Compston J, et al. (2005). Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. Journal of Clinical Endocrinology & Metabolism;90(5):2816-2822. — DOI: 10.1210/jc.2004-1774
  4. Meunier PJ, Slosman DO, Delmas PD, Sebert JL, Brandi ML, et al. (2002). Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis — a 2-year randomized placebo-controlled trial. Journal of Clinical Endocrinology & Metabolism;87(5):2060-2066. — DOI: 10.1210/jc.87.5.2060
  5. Marie PJ (2006). Strontium ranelate: a dual mode of action rebalancing bone turnover in favour of bone formation. Current Opinion in Rheumatology;18(Suppl 1):S11-S15. — DOI: 10.1097/01.bor.0000229522.89546.7b
  6. Abrahamsen B, Grove EL, Vestergaard P (2014). Nationwide registry-based analysis of cardiovascular risk factors and adverse outcomes in patients treated with strontium ranelate. Osteoporosis International;25(2):757-762. — DOI: 10.1007/s00198-013-2469-4
  7. European Medicines Agency / PRAC (2014). Recommendation to restrict the use of strontium ranelate (Protelos/Osseor) due to cardiovascular risk. EMA review. — PubMed (cardiovascular-safety literature)
  8. Strontium dietary intake and essentiality status in humans (no established requirement). — PubMed (intake & essentiality)

PubMed Topic Searches

Back to Table of Contents


Connections

Back to Table of Contents